NCT07712484 clinical trial report covering Olorofim, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07712757 clinical trial report covering DS-1001, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07712588 clinical trial report covering Cyclophosphamide, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262666 clinical trial report covering Toripalimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262772 clinical trial report covering Enzalutamide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262785 clinical trial report covering Relugolix, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262801 clinical trial report covering SYH-2062, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262775 clinical trial report covering VV913, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262786 clinical trial report covering KH-607, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600128388 clinical trial report covering Fulzerasib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07714746 clinical trial report covering Ivabradine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07714525 clinical trial report covering Triamcinolone Acetonide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.